Safety and tolerability of subcutaneous trastuzumab for HER2-positive early breast cancer in patients with lower body weight and in Asian patients: SafeHer Phase III study subgroup analyses

Affiliation auteurs!!!! Error affiliation !!!!
TitreSafety and tolerability of subcutaneous trastuzumab for HER2-positive early breast cancer in patients with lower body weight and in Asian patients: SafeHer Phase III study subgroup analyses
Type de publicationJournal Article
Year of Publication2015
AuteursJung K.H, Ataseven B., Verrill M., De Laurentiis M., Azim H.A, Pivot X., Al-Sakaff N., Lauer S., Shing M., Gligorov J.
JournalEUROPEAN JOURNAL OF CANCER
Volume51
PaginationS318
Date PublishedSEP
Type of ArticleMeeting Abstract
ISSN0959-8049
DOI10.1016/S0959-8049(16)30904-2